Loading...
•
Dec 31, 2023
Lantheus Q4 2023 Earnings Report
Lantheus reported record revenues, earnings, cash flows, and patient impact, advancing its position as the leading radiopharmaceutical-focused company.
Key Takeaways
Lantheus Holdings, Inc. reported a strong Q4 2023 with worldwide revenue of $354.0 million, a 34.5% increase compared to Q4 2022. GAAP net income was $103.4 million, or $1.47 per fully diluted share, compared to a net loss in the prior year. Adjusted fully diluted EPS was $1.75, a 28.0% increase year-over-year. Free cash flow was $100.2 million.
Worldwide revenue for Q4 2023 reached $354.0 million, including a $15.0 million RELISTOR milestone.
GAAP net income for Q4 2023 was $103.4 million, or $1.47 per fully diluted share.
Adjusted fully diluted EPS for Q4 2023 was $1.75, a 28.0% increase compared to Q4 2022.
Free cash flow for Q4 2023 was $100.2 million.
Forward Guidance
The Company provides its guidance for the first quarter and full year 2024 as follows: 1Q 2024 Revenue $347 million - $355 million 1Q 2024 Adjusted Fully Diluted EPS $1.50 - $1.54 FY 2024 Revenue $1.41 billion - $1.445 billion FY 2024 Adjusted Fully Diluted EPS $6.50 - $6.70
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...